VLA4 antagonists (sanofi-aventis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVLA4 antagonists (sanofi-aventis)
Drug Alias NameVLA-4 antagonists (HMR)VLA-4 antagonists (Aventis)IVL-984A2-B2-C7
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsInflammationMultiple SclerosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis PharmaSanofiHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsInflammationMultiple SclerosisAsthma

Other Information

ATC CodeN/A
Related LinksN/A